Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Imprinted SARS-CoV-2-specific memory lymphocytes define hybrid immunity

View ORCID ProfileLauren B. Rodda, View ORCID ProfilePeter A. Morawski, Kurt B. Pruner, Mitchell L Fahning, Christian A. Howard, Nicholas Franko, Jennifer Logue, Julie Eggenberger, Caleb Stokes, Inah Golez, Malika Hale, Michael Gale Jr, Helen Y. Chu, Daniel J. Campbell, View ORCID ProfileMarion Pepper
doi: https://doi.org/10.1101/2022.01.12.22269192
Lauren B. Rodda
1Department of Immunology, University of Washington School of Medicine, Seattle, WA USA, 98109
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lauren B. Rodda
Peter A. Morawski
2Center for Fundamental Immunology, Benaroya Research Institute, Seattle, WA USA, 98101
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Peter A. Morawski
Kurt B. Pruner
1Department of Immunology, University of Washington School of Medicine, Seattle, WA USA, 98109
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mitchell L Fahning
2Center for Fundamental Immunology, Benaroya Research Institute, Seattle, WA USA, 98101
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christian A. Howard
1Department of Immunology, University of Washington School of Medicine, Seattle, WA USA, 98109
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicholas Franko
3Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, USA, 98109
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jennifer Logue
3Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, USA, 98109
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julie Eggenberger
4Department of Immunology, Center for Innate Immunity and Immune Disease, University of Washington, Seattle, WA, USA, 98109
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Caleb Stokes
4Department of Immunology, Center for Innate Immunity and Immune Disease, University of Washington, Seattle, WA, USA, 98109
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Inah Golez
4Department of Immunology, Center for Innate Immunity and Immune Disease, University of Washington, Seattle, WA, USA, 98109
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Malika Hale
5Center for Immunity and Immunotherapies, Seattle Children’s Research Institute, Seattle, WA USA, 98101
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Gale Jr
4Department of Immunology, Center for Innate Immunity and Immune Disease, University of Washington, Seattle, WA, USA, 98109
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Helen Y. Chu
3Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, USA, 98109
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel J. Campbell
1Department of Immunology, University of Washington School of Medicine, Seattle, WA USA, 98109
2Center for Fundamental Immunology, Benaroya Research Institute, Seattle, WA USA, 98101
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marion Pepper
1Department of Immunology, University of Washington School of Medicine, Seattle, WA USA, 98109
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Marion Pepper
  • For correspondence: mpepper@uw.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Summary

Immune memory is tailored by cues that lymphocytes perceive during priming. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic created a situation in which nascent memory could be tracked through additional antigen exposures. Both SARS-CoV-2 infection and vaccination induce multifaceted, functional immune memory, but together they engender improved protection from disease, termed “hybrid immunity”. We therefore investigated how vaccine-induced memory is shaped by previous infection. We found that following vaccination, previously infected individuals generated more SARS-CoV-2 RBD-specific memory B cells and variant-neutralizing antibodies and a distinct population of IFN-γ and IL-10-expressing memory SARS-CoV-2 spike-specific CD4+ T cells than previously naive individuals. While additional vaccination could increase humoral memory, it did not recapitulate the distinct CD4+ T cell cytokine profile in previously naive individuals. Thus, imprinted features of SARS-CoV-2-specific memory lymphocytes define hybrid immunity.

Competing Interest Statement

M.P. is a member of the Scientific Advisory Board of VaxArt and NeoLeukin Inc.

Funding Statement

This work was supported by the following funding: L.B.R. and K.B.P (NIH2T32 AI106677); U. Washington Cell Analysis Facility, Symphony A3 NIH 1S10OD024979-01A1; D.J.C. and P.A.M. (NIH R01AI127726, NIH U19AI125378-S1) and M.P. (NIH U01AI142001-02S1; R01AI118803); BWF #1018486 and COVID Pilot grant to M.P.; and Emergent Ventures Fast Grant to M.P

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Participants were enrolled in the Hospitalized or Ambulatory Adults with Respiratory Viral Infections (HAARVI) study (STUDY00000959), Healthy Adult Specimen Repository study (STUDY00002929) or COVID-19/SARS-CoV-2 Prevalence and Antibody Therapy Development study (Gale Lab, STUDY00009810). All studies are approved by the University of Washington Human Subjects Division Institutional Review Board. Informed consent was obtained from all enrolled participants. Samples were de-identified prior to analysis.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data generated or analysed during this study are included in this published article (and its supplementary information files) or available from the corresponding author upon reasonable request with the exception of a few blood draw samples that were used up in this study. Correspondence and requests for materials should be addressed to M.P.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted January 13, 2022.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Imprinted SARS-CoV-2-specific memory lymphocytes define hybrid immunity
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Imprinted SARS-CoV-2-specific memory lymphocytes define hybrid immunity
Lauren B. Rodda, Peter A. Morawski, Kurt B. Pruner, Mitchell L Fahning, Christian A. Howard, Nicholas Franko, Jennifer Logue, Julie Eggenberger, Caleb Stokes, Inah Golez, Malika Hale, Michael Gale Jr, Helen Y. Chu, Daniel J. Campbell, Marion Pepper
medRxiv 2022.01.12.22269192; doi: https://doi.org/10.1101/2022.01.12.22269192
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Imprinted SARS-CoV-2-specific memory lymphocytes define hybrid immunity
Lauren B. Rodda, Peter A. Morawski, Kurt B. Pruner, Mitchell L Fahning, Christian A. Howard, Nicholas Franko, Jennifer Logue, Julie Eggenberger, Caleb Stokes, Inah Golez, Malika Hale, Michael Gale Jr, Helen Y. Chu, Daniel J. Campbell, Marion Pepper
medRxiv 2022.01.12.22269192; doi: https://doi.org/10.1101/2022.01.12.22269192

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Allergy and Immunology
Subject Areas
All Articles
  • Addiction Medicine (161)
  • Allergy and Immunology (414)
  • Anesthesia (90)
  • Cardiovascular Medicine (858)
  • Dentistry and Oral Medicine (159)
  • Dermatology (97)
  • Emergency Medicine (248)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (394)
  • Epidemiology (8561)
  • Forensic Medicine (4)
  • Gastroenterology (383)
  • Genetic and Genomic Medicine (1749)
  • Geriatric Medicine (167)
  • Health Economics (372)
  • Health Informatics (1242)
  • Health Policy (620)
  • Health Systems and Quality Improvement (467)
  • Hematology (196)
  • HIV/AIDS (372)
  • Infectious Diseases (except HIV/AIDS) (10299)
  • Intensive Care and Critical Care Medicine (553)
  • Medical Education (192)
  • Medical Ethics (51)
  • Nephrology (211)
  • Neurology (1677)
  • Nursing (97)
  • Nutrition (251)
  • Obstetrics and Gynecology (326)
  • Occupational and Environmental Health (450)
  • Oncology (928)
  • Ophthalmology (263)
  • Orthopedics (102)
  • Otolaryngology (172)
  • Pain Medicine (113)
  • Palliative Medicine (40)
  • Pathology (253)
  • Pediatrics (534)
  • Pharmacology and Therapeutics (252)
  • Primary Care Research (208)
  • Psychiatry and Clinical Psychology (1768)
  • Public and Global Health (3837)
  • Radiology and Imaging (623)
  • Rehabilitation Medicine and Physical Therapy (320)
  • Respiratory Medicine (520)
  • Rheumatology (208)
  • Sexual and Reproductive Health (167)
  • Sports Medicine (158)
  • Surgery (190)
  • Toxicology (36)
  • Transplantation (101)
  • Urology (76)